Therefore, based on our results, we will further explore the possibility of improving the prognosis of patients by combining targeted HIF-1α, HIF-2α and IGF1R proteins under the intervention of TMZ, so as to provide new targets and strategies for GBM treatment. This evidence concerns the gene EPAS1 and glioblastoma.